Laborie Medical Technologies is a global developer and manufacturer of innovative medical technology and consumables focused on diagnosing and treating urinary and fecal incontinence, as well as other pelvic floor disorders. The company serves the urology, gynecology, and colorectal fields, providing specialized diagnostic and therapeutic equipment. Laborie is known for its advanced urodynamic testing solutions that help identify the underlying causes of urinary incontinence, thereby facilitating effective treatment options for patients. The company's products aim to improve patient outcomes and enhance the quality of care in healthcare settings.
Bright Uro is an early-stage medical technology company focused on developing innovative diagnostic devices for urology. The company has created a glean urodynamics system that combines advanced hardware, software, and data science to deliver wireless, catheter-free urodynamics. This system aims to enhance the accuracy and comfort of urological assessments, ultimately transforming the standard of care for patients with lower urinary tract symptoms and diseases. By providing actionable insights, Bright Uro empowers clinicians to improve patient outcomes and streamline the treatment process.
Vensica
Venture Round in 2024
Vensica is focused on developing an innovative ultrasound-based drug delivery system aimed at improving the treatment of urinary bladder conditions, particularly bladder cancer and overactive bladder (OAB). Traditional treatment methods involve instilling medication directly into the bladder via a catheter, which can be inefficient and painful. Vensica's approach utilizes ultrasound to enhance drug uptake and penetration into the bladder wall, facilitating a quick and pain-free procedure for patients. This method aims to increase the effectiveness of treatments and reduce the high recurrence rates associated with bladder cancer, which can be as high as 70%. By leveraging ultrasound technology, Vensica seeks to provide safer and more effective treatment options for individuals suffering from these conditions.
I-O Urology
Venture Round in 2024
I-O Urology provides a patient monitoring system for urology.
Bright Uro
Series A in 2023
Bright Uro is an early-stage medical technology company focused on developing innovative diagnostic devices for urology. The company has created a glean urodynamics system that combines advanced hardware, software, and data science to deliver wireless, catheter-free urodynamics. This system aims to enhance the accuracy and comfort of urological assessments, ultimately transforming the standard of care for patients with lower urinary tract symptoms and diseases. By providing actionable insights, Bright Uro empowers clinicians to improve patient outcomes and streamline the treatment process.
Urotronic
Acquisition in 2023
Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, that specializes in developing innovative solutions for urology. Founded in 2014, the company focuses on its flagship product, Optilume, a drug-coated balloon (DCB) catheter designed to treat urethral strictures in men. This minimally invasive device combines balloon dilation with localized drug delivery, utilizing paclitaxel to prevent the recurrence of strictures by limiting cell proliferation and fibrotic scar tissue formation. Urotronic aims to provide urologists and patients with a cost-effective alternative to traditional treatment methods, improving outcomes for individuals suffering from urinary tract conditions.
GIE Medical
Corporate Round in 2023
GIE Medical is a medical organization focused on advancing healthcare through innovative technologies. The company specializes in drug-coated balloon technology aimed at transforming gastroenterology. It is developing an investigational device that undergoes trials for patients suffering from benign strictures of the esophagus and bowel, which includes the small intestine, colon, and rectum. This technology aims to create sustained patency in affected areas, thereby reducing the frequency of treatments required for patients. GIE Medical's commitment to improving patient outcomes is evident in its emphasis on fitness care and diagnostics within its medical offerings.
Novonate
Acquisition in 2023
Novonate is a healthcare technology company focused on improving neonatal care through innovative medical devices. The company's flagship product, LifeBubble, enhances the safety of vascular catheter management in neonatal intensive care units. By providing stronger securement for umbilical catheters, LifeBubble minimizes the risks of catheter migration and premature discontinuation, which are critical concerns in neonatal settings. This device is designed to protect the umbilical catheter insertion site from complications associated with central lines, thereby ensuring safer and more stable care for vulnerable infants during medical procedures such as phlebotomy.
GI Supply
Acquisition in 2022
GI Supply, Inc. is a manufacturer of specialized medical products designed for gastroenterologists, colorectal surgeons, and interventional radiologists. Founded by Dr. Frank Jackson in 1982, the company is headquartered in Mechanicsburg, Pennsylvania. Its product lineup includes endoscopic tattoo agents, submucosal lifting agents, endoscopic injection needles, and paracentesis management systems, among others. These products are developed in collaboration with healthcare professionals to address clinical challenges and enhance both physician efficiency and patient satisfaction. Today, GI Supply's innovative solutions are utilized daily by medical practitioners in over 40 countries worldwide.
Vensica
Venture Round in 2021
Vensica is focused on developing an innovative ultrasound-based drug delivery system aimed at improving the treatment of urinary bladder conditions, particularly bladder cancer and overactive bladder (OAB). Traditional treatment methods involve instilling medication directly into the bladder via a catheter, which can be inefficient and painful. Vensica's approach utilizes ultrasound to enhance drug uptake and penetration into the bladder wall, facilitating a quick and pain-free procedure for patients. This method aims to increase the effectiveness of treatments and reduce the high recurrence rates associated with bladder cancer, which can be as high as 70%. By leveraging ultrasound technology, Vensica seeks to provide safer and more effective treatment options for individuals suffering from these conditions.
Pelvalon
Acquisition in 2021
Pelvalon is a medical device company focused on improving the lives of women affected by fecal incontinence and pelvic floor disorders. The company develops non-surgical therapy devices that do not contain drugs or hormones, providing effective treatment options for accidental bowel leakage. By addressing the specific needs of female pelvic and bowel health, Pelvalon aims to enhance bowel control and overall well-being for its patients.
Clinical Innovations
Acquisition in 2019
Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Since its inception in 1993, Clinical Innovations has consistently expanded its worldwide presence, becoming the market leader in several product categories. This growth has fueled the ability to invest in new product ideas where innovation makes the difference. And with a management team with extensive experience in the medical device industry, Clinical Innovations possesses the working knowledge to develop those new product ideas into industry-changing specialty devices. Clinical Innovations is dedicated to quality and customer service. With ISO13485 certification and strong relationships with top worldwide medical distributors, Clinical Innovations has the systems and infrastructure in place to promptly respond to market trends and customer suggestions. Clinical Innovations is a Prizker Group Company.
Cogentix Medical
Acquisition in 2018
Cogentix Medical, Inc. is a medical device company based in Minnetonka, Minnesota, specializing in the design, development, manufacturing, and marketing of advanced fiberoptic and video endoscopy products under the PrimeSight brand. The company offers a variety of endoscopes, including cystoscopes and bronchoscopes, along with the EndoSheath Protective Barrier, a sterile, single-use microbial barrier for flexible endoscopes. Cogentix Medical is also known for its Urgent PC System, which provides percutaneous tibial nerve stimulation for the treatment of overactive bladder, and Macroplastique, an injectable urethral bulking agent for adult female stress urinary incontinence. In addition to these products, the company distributes wound care products in the Netherlands and the United Kingdom. Cogentix Medical operates through a direct sales force and a network of distributors, having been formed in 2015 through the merger of Uroplasty and Vision-Sciences.
Andromeda
Acquisition in 2017
ANDROMEDA medizin Systeme GmbH was founded in 1994. ANDROMEDA develops and markets modern and high-quality Urodynamic instruments. As a specialist and pioneer, the company is now one of the world's leading manufacturers of urodynamics.
iTind
Funding Round in 2016
iTind, developed by Medi-Tate Ltd., is a medical device designed to treat benign prostatic hyperplasia (BPH) through a non-surgical procedure. This temporarily implanted nitinol device is placed in the prostatic urethra for five days, during which it displaces obstructive tissue, reshaping the prostate and providing long-lasting relief from BPH symptoms. The iTind device is approved for sale in several regions, including the European Union, UK, Israel, Australia, Brazil, and it has received FDA clearance for use in the United States. Founded in 2007 and based in Or Akiva, Israel, Medi-Tate Ltd. aims to enhance men's healthcare and improve quality of life through effective, minimally invasive solutions.
Medical Measurement Systems
Acquisition in 2015
Medical Measurement Systems B.V. specializes in the manufacture and distribution of diagnostic equipment aimed at urodynamic and gastrointestinal testing. The company provides a range of products including Uroflowmetry, Urodynamics, Ambulatory Urodynamics, Video Urodynamics, Neuro-Urodynamics, and assessments of pelvic floor strength and bladder function. Additionally, it offers gastrointestinal diagnostic tools such as Impedance measurement, pH Reflux measurement, High-Resolution Manometry, and various manometry tests for the small bowel and colon. Medical Measurement Systems also emphasizes education by providing customized training programs for healthcare professionals, including physicians and technicians. Its products are utilized in small hospitals, private clinics, university hospitals, and research centers. Founded in 1988 and based in Enschede, the Netherlands, the company operates as a subsidiary of Laborie Medical Technologies, Inc.
Unisensor
Acquisition in 2014
Unisensor is a manufacturer specializing in medical-use sensors and catheters, focusing on the development and production of advanced measurement devices. The company creates multipoint catheters, as well as pressure and pH catheters designed for gastroenterology applications. Additionally, Unisensor produces transurethral and anorectal measurement catheters specifically for urology. One of its notable innovations is the Compartment System Measuring System, which aids in the diagnosis and treatment of muscle compartment syndrome. Through these products, Unisensor contributes to the advancement of medical diagnostics and therapeutic interventions.
BUCK Elektromedizin
Acquisition in 2014
BUCK Elektromedizin is a medical technology company that specializes in the development and distribution of therapy and diagnostic equipment for the treatment of urinary and fecal incontinence. The company offers a range of products including EMG home biofeedback systems, electrical stimulation devices, and combination systems designed for use in various medical fields such as gynecology, urology, coloproctology, neurology, and speech therapy. Additionally, BUCK Elektromedizin provides clinical psychological treatment solutions and urodynamic and anorectal measuring stations. The company's focus is on enhancing diagnosis and rehabilitation in these specialized areas of medicine.
Mediwatch
Acquisition in 2013
Mediwatch is a manufacturer and distributor specializing in diagnostic products for urological and gastrointestinal disorders. The company provides a range of equipment including urodynamics systems, bladder scanners, uroflowmeters, PSA testing products, pelvic floor biofeedback instruments, and anorectal manometry systems. Mediwatch aims to enhance the screening, diagnosis, and treatment of conditions related to these medical fields, thereby contributing to improved patient care and outcomes.
UroMed Technology - Pelvic Muscle Rehabilitation Business
Acquisition in 2013
UroMed Technology - Pelvic Muscle Rehabilitation Business is a provider of pelvic muscle rehabilitation services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.